13th Update on the Management of Genitourinary Malignancies
- November 10, 2018 Ends at 4:00 p.m.
The 13th Update on the Management of Genitourinary Malignancies Conference will focus on the diagnosis, treatment, clinical advances, and controversies in localized and advanced cancers of the bladder, kidney, bladder, prostate, upper tract, penile and testis cancers.
After attending the conference, participants should be able to:
- Evaluate, counsel and treat patients with rare genitourinary malignancies (penile cancer, testicular cancer, adrenal tumors) (Knowledge, Competence, Performance);
- Utilize cytoreductive surgery, adjuvant therapies and systemic therapies for patients with kidney cancer (small renal masses, locally advanced tumors, metastatic tumors) (Knowledge, Competence, Performance);
- Assess the molecular characterization, non-muscle invasive tumors and muscle-invasive tumors to provide optimal treatment for patients with urothelial carcinoma (Knowledge, Competence. Performance, Patient Outcomes);
- Evaluate, counsel and treat patients with prostate cancer (screening, early disease/focal therapy, radiation therapy, high-risk disease, and recurrent/metastatic disease) (Knowledge, Competence, Performance).
- Case presentations
- Panel discussions
- Audience Response System
- Question and discussion sessions
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
The University of Texas MD Anderson Cancer Center
1155 Pressler St., Houston, TX 77030